Biotech Investors

IQnovate seeks to lead the investment community, practitioners and observers in establishing the Biotech Industry as a critical alternative asset option within the alternative asset class.

AN INVESTMENT OPTION THAT SEEKS TO:

  • Efficiently supply the pathway to the development of medicines
    of the future
  • Effectively eradicate disease through private enterprise investment
  • Generate consistent market returns for investors

WE OFFER ADVISORY SERVICES INCLUDING:

  • New technology evaluations and investment opportunities
  • R&D strategies, projects and portfolios
  • Advising on R&D management and new product development
  • Development of policy with governments in R&D and science & technology

ALIGNING BIOTECH WITH CAPITAL

All of the unique features of the life science industry have one factor in common: they all affect risk. Valuation models are only as good as the assumptions behind the numbers.

  • We understand the business of biotech, we have been there
  • We know the people creating the drugs of the future, we’ve worked with them
  • We know the challenges the biotech teams deal with
  • We’ve dealt with them and succeeded

This grants us a unique perspective of the biotech industry, enabling us to create partnerships that will result in the biotech sector development through private enterprise investment.

Prior to introducing the biotech to the investment community IQnovate will work with the company towards developing a tangible, risk managed business plan from preclinical to registration, with a clearly defined exit strategy for the investor, provide scientific expertise on CCDP and LCCDP, advice the BoD on most suitable business model. IQnovate will then introduce the company to the relevant investor group, present valuation models, and facts. Advise both parties during the transaction and continue advising both parties as needed.

 

IMPORTANT INFORMATION: IQNovate Ltd ACN 149 731 644 (“IQN”) is not a holder of a Australian Financial Services Licence. The information contained in this website is of a general nature only and is not intended for any person or legal entity to rely or act on such information when making an investment decision. IQN is not a provider of any financial product or financial advice and strongly recommend that you seek the advice of suitably qualified professionals.

Site by Emedia Creative